Right Choice P.m. Multi Formula - Caplet 33 mg Tablet is a Health Canada–registered human drug (DIN 02229686) held by Body Wise International LLC, containing Potassium (Potassium Chloride). Health Canada lists its status as Cancelled (Unreturned Annual) (status date 12 Oct 2018). Nexara Health has matched 601 registrations of Potassium (Potassium Chloride) across 16 other regulated markets.
Health Canada registration
| DIN | 02229686 |
|---|---|
| Brand name | Right Choice P.m. Multi Formula - Caplet |
| Active ingredient | Potassium (Potassium Chloride) |
| Strength | 33 mg |
| Dosage form | Tablet |
| Route | Oral |
| Company | Body Wise International LLC |
| Status | Cancelled (Unreturned Annual) — 12 Oct 2018 |
| Class | Human |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Potassium (Potassium Chloride) registered in other markets
601 registrations of the same molecule in 16 national registries outside Canada (first 90 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Australia | Potassium Citrate | — | EP | PBS | ||
| Australia | Span-K | As | Tablet 600 mg (sustained release) | GE | PBS | |
| Australia | Span-K | As | Tablet 600 mg (sustained release) | GE | PBS | |
| Bahrain | 15% Potassium Chloride | Pharmaceutical Solution Industry Ltd (Psi), Ksa. | 15 % W/V | Solution For Infusion | POM | NHRA |
| Bulgaria | Kalium chlorid Braun | B.Braun Melsungen AG | 14,9% concentrate for solution for infusion | концентрат за инфузионен разтвор | По лекарско предписание | BDA |
| Bulgaria | Nefromeltar | Tarchominskie Zaklady Farmaceutyczne Polfa S.A. | Nefrocitran 1080 mg modified-release tablet | таблетки с изменено освобождаване | По лекарско предписание | BDA |
| Finland | Libromide | Dechra Regulatory B.V. | 325 mg | tabletti | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Vetbromide | Domes Pharma | 600 mg | tabletti | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Greece | Tentil Ey.dro.sol 0.3%+0.3% Flx15ml | Rafarm A.e.b.e. | non-reimbursed | MoH deltio timwn | ||
| Hong Kong | Duro-K 600 Tab 600mg | Vickmans Laboratories Ltd | Registered | DH Drug Office | ||
| Hong Kong | Highly Concentrated Potassium Chloride Inj (10meq) (Baxter Usa) | Baxter Healthcare Limited | Registered | DH Drug Office | ||
| Hong Kong | Highly Concentrated Potassium Chloride Inj (20meq) (Baxter Usa) | Baxter Healthcare Limited | Registered | DH Drug Office | ||
| Hong Kong | Kalinor Retard Prolonged-Release Capsules 600mg | Hind Wing Co Ltd | Registered | DH Drug Office | ||
| Hong Kong | Potassium Chloride Concentrate For Solution For Infusion 10.0% W/V | Healthcare Pharmascience Limited | Registered | DH Drug Office | ||
| Hong Kong | Potassium Chloride Concentrate For Solution For Infusion 14.9% W/V | B. Braun Medical (Hk) Ltd | Registered | DH Drug Office | ||
| Hong Kong | Potassium Chloride Extended-Release Tablets 600mg | W Corporation Limited | Registered | DH Drug Office | ||
| Hong Kong | Potassium Chloride Extended-Release Tablets USP 600mg | Chemill Pharma Limited | Registered | DH Drug Office | ||
| Hungary | Kaldyum 600 mg Retard Kemény Kapszula | Egis Gyógyszergyár Zártkörűen Működő Részvénytársaság | 50x üvegben | NEAK PUPHA | ||
| Hungary | Kaldyum 600 mg Retard Kemény Kapszula | Egis Gyógyszergyár Zártkörűen Működő Részvénytársaság | 100x üvegben | NEAK PUPHA | ||
| Hungary | Kálium-R Tabletta | Bausch Health Ireland Limited | 50x buborékcsomagolásban | NEAK PUPHA | ||
| Hungary | Kálium-R Tabletta | Bausch Health Ireland Limited | 30x buborékcsomagolásban | NEAK PUPHA | ||
| Hungary | Tabletta Kalii Citratis Fono Viii. Naturland | Naturland Magyarország Termelő és Kereskedelmi Korlátolt Felelősségű Társaság | 20x buborékcsomagolásban | NEAK PUPHA | ||
| Iceland | Acalka | Lyfjaver - óskráð lyf | 1080 mg | forðatfl | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Acalka | Parlogis - óskráð lyf | 1080 mg | forðatfl | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Alkacit | XGX Pharma ApS | 10 mEq | töflur | 1 | Lyfjastofnun lyfjaverdskra |
| Iceland | Polycítra - forskriftarlyf | PharmArctica - forskriftarlyf | mixtúra | 7 | Lyfjastofnun lyfjaverdskra | |
| Iceland | Uralyt-U | Vistor - óskráð | kyrni | 0 | Lyfjastofnun lyfjaverdskra | |
| Ireland | Cystopurin 3g Granules for oral solution | Bayer Limited | Granules for oral solution | Marketed | HPRA | |
| Ireland | Kacital 1080 mg modified-release tablets | XGX Pharma ApS | Modified-release tablet | Not marketed | HPRA | |
| Ireland | Kay-Cee-L Syrup 7.5% w/v | Syri Pharma Limited t/a Thame Laboratories | Syrup | Marketed | HPRA | |
| Ireland | Potassium Chloride 15% w/v Concentrate for solution for infusion | Noridem Enterprises Limited | Concentrate for solution for infusion | Not marketed | HPRA | |
| Ireland | Potassium Chloride 15% w/v Concentrate for Solution for Infusion | Mercury Pharmaceuticals (Ireland) Ltd | Concentrate for solution for infusion | Marketed | HPRA | |
| Ireland | Potassium Chloride 15% w/v Concentrate for Solution for Infusion | Fresenius Kabi Deutschland GmbH | Concentrate for solution for infusion | Not marketed | HPRA | |
| Ireland | Potassium Chloride 15% w/v Concentrate for Solution for Infusion | B. Braun Medical Limited | Concentrate for solution for infusion | Marketed | HPRA | |
| Ireland | Slow K 600mg Prolonged-release Coated Tablets | Essential Pharma (M) Limited | Prolonged-release tablet | Not marketed | HPRA | |
| Saudi Arabia | 15% W-V Potassium Chloride For Inj. USP | — | 15 | Inactive | SFDA | |
| Saudi Arabia | 15% W-V Potassium Chloride For Inj. USP | — | 15 | Inactive | SFDA | |
| Saudi Arabia | 15% W-V Potassium Chloride For Inj. USP | — | 15 | Inactive | SFDA | |
| Saudi Arabia | K-cit | — | 5 | Inactive | SFDA | |
| Saudi Arabia | K-cit | — | 10 | Inactive | SFDA | |
| Saudi Arabia | Potassium Acetate Inj F.t.v. 40meq | — | 40 | Inactive | SFDA | |
| Saudi Arabia | Potassium Chloride | — | 10 | Inactive | SFDA | |
| Saudi Arabia | Potassium Chloride | — | 15 | Inactive | SFDA | |
| Singapore | DBL POTASSIUM ACETATE CONCENTRATED INJECTION 2.45 g/5 ml | Pfizer Private Limited | 2.45 g/5 ml | Injection | Prescription Only | HSA |
| Singapore | POTASSIUM CHLORIDE INJECTION - HIGHLY CONCENTRATED (100 mEq/l) | Baxter Healthcare (Asia) Pte Ltd | 746 mg/100 ml | Injection | Prescription Only | HSA |
| Singapore | POTASSIUM CHLORIDE INJECTION - HIGHLY CONCENTRATED (200 mEq/l) | Baxter Healthcare (Asia) Pte Ltd | 746 mg/50 ml | Injection | Prescription Only | HSA |
| Singapore | POTASSIUM CHLORIDE INJECTION - HIGHLY CONCENTRATED (400 mEq/l) | Baxter Healthcare (Asia) Pte Ltd | 1.49 g/50 ml | Injection | Prescription Only | HSA |
| Singapore | POTASSIUM CHLORIDE MIXTURE 500 mg/5 ml | Beacons Pharmaceuticals Pte. Ltd. | 500 mg/5 ml | Solution | Prescription Only | HSA |
| Singapore | POTASSIUM CHLORIDE TABLETS (SLOW-RELEASE) 600 mg (YELLOW) | Beacons Pharmaceuticals Pte. Ltd. | 600 mg | Tablet | Prescription Only | HSA |
| Singapore | Sterile Potassium Chloride Concentrate Injection 7.45% | B. Braun Singapore Pte Ltd | 7.45 g/100 ml | Injection | Prescription Only | HSA |
| Singapore | UROCIT-K TABLET 1080 mg | Sg Healthcare Pte. Ltd. | 1080 mg | Tablet | General Sale List | HSA |
| South Africa | Cardioplegic Induction Solution Fresenius | Fresenius Kabi Manufacturing SA (Pty) Ltd | 3757 g/500 ml | Sol | S3 | DoH SEP database |
| South Africa | Cardioplegic Induction Solution Fresenius | Fresenius Kabi Manufacturing SA (Pty) Ltd | g/500 ml | Sol | S3 | DoH SEP database |
| South Africa | Cardioplegic Induction Solution Fresenius | Fresenius Kabi Manufacturing SA (Pty) Ltd | 3757 g/500 ml | Sol | S3 | DoH SEP database |
| South Africa | Cardioplegic Maintenance Solution Fresenius | Fresenius Kabi Manufacturing SA (Pty) Ltd | 1375 g/500 ml | Inf | S3 | DoH SEP database |
| South Africa | Cardioplegic Maintenance Solution Fresenius | Fresenius Kabi Manufacturing SA (Pty) Ltd | 1375 g/500 ml | Inf | S3 | DoH SEP database |
| South Africa | Cardioplegic Maintenance Solution Fresenius | Fresenius Kabi Manufacturing SA (Pty) Ltd | 1375 g/500 ml | Inf | S3 | DoH SEP database |
| South Africa | Cardioplegic Reperfusion Solution Fresenius | Fresenius Kabi Manufacturing SA (Pty) Ltd | g/500 ml | Sol | S3 | DoH SEP database |
| South Africa | Cardioplegic Reperfusion Solution Fresenius | Fresenius Kabi Manufacturing SA (Pty) Ltd | g/500 ml | Sol | S3 | DoH SEP database |
| Taiwan | "U-Liang"Potassium Acetate Injection 2meq/mL | 瑞士藥廠股份有限公司新市廠 | 注射劑 | Registered | TFDA | |
| Taiwan | 0.149% KCl in 0.9% NaCl Injection "Chi Sheng" | 濟生醫藥生技股份有限公司 | 注射液劑 | Registered | TFDA | |
| Taiwan | 0.149% KCl in 0.9% NaCl Injection“TBC” | 信東生技股份有限公司 | 注射液 | Registered | TFDA | |
| Taiwan | 0.298% KCl in 0.9% NaCl Injection "Chi Sheng" | 濟生醫藥生技股份有限公司 | 注射液 | Registered | TFDA | |
| Taiwan | 0.298% KCl in 0.9% NaCl Injection“TBC” | 信東生技股份有限公司 | 注射液 | Registered | TFDA | |
| Taiwan | 1.49% Potassium Chloride in water Injection "TBC" | 信東生技股份有限公司 | 注射劑 | Registered | TFDA | |
| Taiwan | Addi-K Leo | Leo Pharmaceutical Products | 膜衣錠 | 已註銷 | TFDA | |
| Taiwan | Addi-K Tablets 750mg | Leo Pharmaceutical Products | 膜衣錠 | 已註銷 | TFDA | |
| Turkey | Potas.kl %7.5 10 mL 10 Ampul | Osel İlaç San. Ve Ti̇c. A.ş. | Aktif | TITCK | ||
| Turkey | Potasyum Klorur %22.5 10 mL 10 Ampul | Galen İlaç San.ve Ti̇c.a.ş | Aktif | TITCK | ||
| Turkey | Potasyum Klorur %7,5 Sibu Pharm Enjeksiyonluk Cozelti (10 Ampul) | Si̇bu Pharm İlaç Sanayi̇ Ve Diş Ti̇caret Anoni̇m Şi̇rketi̇ | Aktif | TITCK | ||
| Turkey | Potasyum Klorur %7.5 10 mL 10 Ampul | Galen İlaç San.ve Ti̇c.a.ş | Aktif | TITCK | ||
| Turkey | Potasyum Klorur Onfarma %7,5 10 mL 10 Ampul | Onfarma İlaç Sanayi̇ Ltd.şti̇. | Aktif | TITCK | ||
| Turkey | Turktipsan Potasyum Klorur 750 mg / 10 mL Enjeksiyonluk Cozelti Iceren Ampul (10 Ampul) | Turktipsan Sağlik Turi̇zm Eği̇ti̇m Ve Ti̇caret A.ş. | Aktif | TITCK | ||
| Turkey | Urocit-K(10 Meq) 1080 mg 100 Kontrollu Salim Tableti | Aymed İlaç.san.ti̇c.ltd.şti̇. | Aktif | TITCK | ||
| United Arab Emirates | Kidnitan+ Sachets | UAB ACONITUM, Lithuania, Kaunas | Combination | Powder | Active | EDE |
| United Arab Emirates | Kidnitan+ Sachets | UAB ACONITUM, Lithuania, Kaunas | Combination | Powder | Active | EDE |
| United Arab Emirates | Odan Potassium Chloride Liquid | Odan Laboratories Ltd. , Canada, Quebec | 20mEq/15mL | Liquid | Active | EDE |
| United Arab Emirates | Potassium Chloride 0.15% w/v and Glucose 5% w/v(Viaflo)[Baxter] | Bieffe Medital S.A, Spain, Sabiñanigo | combination | Infusion | Active | EDE |
| United Arab Emirates | Potassium Chloride 0.3% w/v and Glucose 5% w/v (Viaflo) [Baxter] | Bieffe Medital S.A, Spain, Sabiñanigo | combination | Infusion | Active | EDE |
| United Arab Emirates | Potassium Chloride 15% w/v (Gulf Inject) | GULF INJECT LLC, United Arab Emirates, Dubai | 15% w/v | Infusion | Active | EDE |
| United Arab Emirates | POTASSIUM CHLORIDE AGUETTANT 0.15 g/ml (15%) | LABORATOIRE AGUETTANT, France, Champagne-Serrieres | 15% | Infusion | Active | EDE |
| United Arab Emirates | POTASSIUM CHLORIDE S.A.L.F. 2 mEq/ml | S.A.L.F. SPA LABORATORIO FARMACOLOGICO, Italy, Cenate Sotto (BG) | 2 mEq/ml | Infusion | Active | EDE |
| United States | Attitude Adult Fluoride-free - Sensitive - Spearmint | 9055-7588 Québec Inc. DBA Attitude | Gel, Dentifrice | listed | FDA NDC | |
| United States | Bestmade Natural Products Potassium Bromide (Kali Brom) | Bestmade Natural Products | Tablet, Soluble | listed | FDA NDC | |
| United States | BM Potassium bromide (Kali Brom) | BM Private Limited | Tablet | listed | FDA NDC | |
| United States | Boka Sensitive | Karaka LLC | Paste, Dentifrice | listed | FDA NDC | |
| United States | D-125 | DNA Labs, Inc. | Solution | listed | FDA NDC | |
| United States | D-127 | DNA Labs, Inc. | Solution | listed | FDA NDC | |
| United States | GuruNanda Sensitive | Gurunanda, LLC | Paste | listed | FDA NDC | |
| United States | Kali bromatum | Boiron | Pellet | listed | FDA NDC |
See every manufacturer of Potassium (Potassium Chloride) worldwide →
Regulator price references for Potassium (Potassium Chloride)
Published list or reimbursement prices for Potassium (Potassium Chloride) presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Australia | Span-K | Tablet 600 mg (sustained release) | 15.27 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Span-K | Tablet 600 mg (sustained release) | 15.27 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Bahrain | 15% Potassium Chloride | 15pct | 10ML | 0.12 BHD | retail (max) | NHRA | 2026-09-01 |
| Greece | Tentil Ey.dro.sol 0.3%+0.3% Flx15ml | 0.3pct+0.3pct+15ml | 0.99 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Hungary | Tabletta Kalii Citratis Fono Viii. Naturland | 20x buborékcsomagolásban | 623.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 | |
| Hungary | Kálium-R Tabletta | 30x buborékcsomagolásban | 814.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 | |
| Hungary | Kaldyum 600 mg Retard Kemény Kapszula | 600mg | 50x üvegben | 1,189.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Hungary | Kálium-R Tabletta | 50x buborékcsomagolásban | 1,356.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 | |
| Hungary | Kaldyum 600 mg Retard Kemény Kapszula | 600mg | 100x üvegben | 1,480.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Iceland | Uralyt-U | glas | 7,054.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 | |
| Iceland | Acalka | 1080mg | glas | 9,541.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Acalka | 1080mg | pakki | 10,647.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Alkacit | glas | 15,725.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 | |
| Iceland | Polycítra - forskriftarlyf | fl | 24,900.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 | |
| Saudi Arabia | 15% W-V Potassium Chloride For Inj. USP | 15pct | 0.70 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Potassium Chloride | 1.10 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Potassium Chloride 7.5% Amp | 7.5pct | 1.45 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Potassium Chloride 7.5% Amp | 7.5pct | 1.75 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Potassium Chloride Strong(15%) Amp 10ml | 10ml+15pct | 2.05 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | 15% W-V Potassium Chloride For Inj. USP | 15pct | 2.20 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Potassium Phosphate Inj 20miniplasco Amp | 2.30 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Potassium Chloride 7.5% Amp | 7.5pct | 2.60 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | 15% W-V Potassium Chloride For Inj. USP | 15pct | 3.95 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | POTASSIUM CHLORIDE 20mEq FTV. ADDITIVE | 4.25 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | POTASSIUM PHOSPHATE FTV 15mM-5MLADDITIVE | 5.80 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | POTASSIUM CHLORIDE 1.5% injection USP | 1.5pct | 8.00 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | POTASSIUM CHLORIDE 10mEqFTV ADDITIVE INJ | 8.80 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | POTASSIUM PHOSPHATE 45mM-15ML ADDITIVE | 15ml | 9.15 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Ultra-K Syrup | 9.95 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Potassium Acetate Inj F.t.v. 40meq | 11.20 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Potassium Chloride Strides | 50.15 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Zyutra | 51.70 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Potassium Chloride Extended-Release Tablets USP | 52.80 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Potassium Chloride 7.45% Inj Amp | 7.45pct | 63.85 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Zyutra | 103.45 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | K-cit | 147.35 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | K-cit | 294.70 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Potassium Chloride | 326.70 SAR | public | SFDA | 2026-09-01 | ||
| South Africa | Neolyte | 224mg/200ml | 200 | 31.72 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Modified Ringer-Lactate Solution Fresenius | 1000 | 39.04 ZAR | single exit price | DoH SEP database | 2026-09-01 | |
| South Africa | Ultipot | 600mg | 30 | 50.10 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Sandoz K-600 | 600mg | 30 | 55.63 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Sabax Potassium Chlor 15% (10ml) | 10ml | 10 | 75.09 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Potassium Chloride B.Braun 14.9% | 14900mg/100ml | 10 | 115.29 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Potassium Chloride Fresenius 15% "Flexivial" | 10ml | 10 | 124.68 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Potassium Chloride Fresenius 15% | 15pct | 10 | 161.73 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Ultipot | 600mg | 100 | 167.13 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Plenish-K | 600mg | 100 | 183.30 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Plenish-K 600 SR | 600mg | 100 | 185.60 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Sandoz K-600 | 600mg | 100 | 185.84 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Cardioplegic Maintenance Solution Fresenius | 1375000mg/500ml | 500 | 224.81 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Cardioplegic Induction Solution Fresenius | 500ml | 500 | 233.58 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Cardioplegic Reperfusion Solution Fresenius | 500ml | 500 | 274.58 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Potassium Chloride Fresenius 15% "Flexivial" | 15000mg/10ml | 10 | 311.70 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Modified Ringer-Lactate Solution Fresenius | 1000 | 468.51 ZAR | single exit price | DoH SEP database | 2026-09-01 | |
| South Africa | Slow-K | 600mg | 500 | 690.26 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Ultipot | 600mg | 500 | 835.59 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Plenish-K | 600mg | 500 | 916.51 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Sandoz K-600 | 600mg | 500 | 929.31 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Potassium Chloride Unicorn 600 | 600mg | 500 | 936.70 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Neolyte | 224mg/200ml | 200 | 951.67 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Neolyte | 224mg/200ml | 200 | 1,268.90 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Cardioplegic Maintenance Solution Fresenius | 1375000mg/500ml | 500 | 4,046.74 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Cardioplegic Induction Solution Fresenius | 3757000mg/500ml | 500 | 4,204.54 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Cardioplegic Maintenance Solution Fresenius | 1375000mg/500ml | 500 | 4,496.39 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Cardioplegic Induction Solution Fresenius | 3757000mg/500ml | 500 | 4,671.71 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Cardioplegic Reperfusion Solution Fresenius | 500ml | 500 | 4,942.63 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Cardioplegic Reperfusion Solution Fresenius | 500ml | 500 | 5,491.81 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| United Arab Emirates | Potassium Chloride 15% w/v (Gulf Inject) | 15pct | 5 x10 ml LDPE Ampoules | 24.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | POTASSIUM CHLORIDE S.A.L.F. 2 mEq/ml | 5 Glass Ampoule x 10 ml | 34.00 AED | public | EDE | 2026-08-31 | |
| United Arab Emirates | Potassium Chloride 0.15% w/v and Glucose 5% w/v(Viaflo)[Baxter] | 0.15pct+5pct | 20 Viaflo Bags (500 mL) | 142.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Potassium Chloride 0.3% w/v and Glucose 5% w/v (Viaflo) [Baxter] | 0.3pct+5pct | 20 Viaflo Bags (500 mL) | 152.50 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | POTASSIUM CHLORIDE AGUETTANT 0.15 g/ml (15%) | 15pct | 50 Polypropylene Ampoules (10 ml) | 172.00 AED | public | EDE | 2026-08-31 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Right Choice P.m. Multi Formula - Caplet (DIN 02229686) marketed in Canada?
No. Health Canada lists DIN 02229686 as Cancelled (Unreturned Annual) as of 12 Oct 2018.
Who holds the Canadian licence for this product?
Body Wise International LLC is the company of record in the Health Canada Drug Product Database.
Is Potassium (Potassium Chloride) registered outside Canada?
Yes — Nexara Health has matched 601 registrations in 16 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02229686, status date 2018-10-12; national medicine registries: BDA, DH Drug Office, DoH SEP database, EDE, FDA NDC, Fimea Perusrekisteri, HPRA, HSA, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NEAK PUPHA, NHRA, PBS, SFDA, TFDA, TITCK; price sources: DoH SEP database, EDE, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NEAK PUPHA, NHRA, PBS, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02229686, status date 2018-10-12; national medicine registries: BDA, DH Drug Office, DoH SEP database, EDE, FDA NDC, Fimea Perusrekisteri, HPRA, HSA, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NEAK PUPHA, NHRA, PBS, SFDA, TFDA, TITCK; price sources: DoH SEP database, EDE, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NEAK PUPHA, NHRA, PBS, SFDA.
Health Canada Drug Product Database (DPD), DIN 02229686, status date 2018-10-12; national medicine registries: BDA, DH Drug Office, DoH SEP database, EDE, FDA NDC, Fimea Perusrekisteri, HPRA, HSA, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NEAK PUPHA, NHRA, PBS, SFDA, TFDA, TITCK; price sources: DoH SEP database, EDE, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NEAK PUPHA, NHRA, PBS, SFDA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.